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ABSTRACT
The aim of this study was to investigate whether cinnamon bark oil (CBO) has protective effect on
taxanes-induced adverse changes in sperm quality, testicular and epididymal oxidant/antioxidant
balance, testicular apoptosis, and sperm DNA integrity. For this purpose, 88 adult male rats were
equally divided into 8 groups: control, CBO, docetaxel (DTX), paclitaxel (PTX), DTXCPTX, DTXCCBO,
PTXCCBO, and DTXCPTXCCBO. CBO was given by gavage daily for 10 weeks at the dose of
100 mg/kg. DTX and PTX were administered by intraperitoneal injection at the doses of 5 and 4 mg/
kg/week, respectively, for 10 weeks. DTXCPTX and DTXCPTXCCBO groups were treated with DTX
during first 5 weeks and PTX during next 5 weeks. DTX, PTX, and their mixed administrations caused
significant decreases in absolute and relative weights of all reproductive organs, testosterone level,
sperm motility, concentration, glutathione level, and catalase activity in testicular and epididymal
tissues. They also significantly increased abnormal sperm rate, testicular and epididymal
malondialdehyde level, apoptotic germ cell number, and sperm DNA fragmentation and
significantly damaged the histological structure of testes. CBO consumption by DTX-, PTX-, and
DTXCPTX-treated rats provided significant ameliorations in decreased relative weights of
reproductive organs, decreased testosterone, decreased sperm quality, imbalanced oxidant/
antioxidant system, increased apoptotic germ cell number, rate of sperm with fragmented DNA,
and severity of testicular histopathological lesions induced by taxanes. In conclusion, taxanes cause
impairments in sperm quality, testicular and epididymal oxidant/antioxidant balance, testicular
histopathological structure, and sperm DNA integrity, and long-term CBO consumption protects
male reproductive system of rats.
Introduction
Docetaxel (DTX) and paclitaxel (PTX) are the taxane
class of drugs which are among the most effective che-
motherapeutic agents (1). They have the same effect and
exhibit their chemotherapeutic influences through poly-
merization of tubulin monomer, leading to mitotic arrest
inducing phosphorylation of Bcl-2, a protein producing
anti-apoptotic effects, and apoptotic cell death (2–4).
PTX is a natural diterpene originally extracted from the
bark of the Pacific yew tree, Taxus brevifolia (5). DTX,
extracted from Taxus baccata (European yew tree), is a
semisynthetic analog of PTX (6). Both PTX and DTX
have a broad spectrum of antitumor activity and they are
widely used in the treatment of various types of cancers
such as breast, non-small cell lung, advanced stomach,
head and neck, and metastatic prostate cancer (2,7,8).
Nowadays, a high percentage of cancer patients are
treated by using chemotherapeutic agents. Long-term
exposure to chemotherapeutic agents leads to damage in
reproductive system (9,10). Reproductive organs, espe-
cially testes, are the target organs for the damage result-
ing from chemotherapeutic agents. The testis produces
mature gametes through spermatogenesis which is nega-
tively affected when exposed to chemotherapeutic agents
(9,11). Spermatogenesis is unfavorably affected by
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secretory substances of the tumor, such as hormones and
cytokines and chemotherapeutic agents (12). Chemo-
therapeutic agents easily reach Leydig and Sertoli cells
and spermatogonia. Many chemotherapeutic agents can
penetrate the Sertoli cell barrier and lead to damage of
the late-stage germ cells. Particularly, differentiating
spermatogonia are highly vulnerable to cytotoxic agents
(13). In animal studies, it has been shown that chemo-
therapies lead to mutations; later-stage spermatogenic
cells (spermatocytes onward) are vulnerable to muta-
genic injury—the mutated DNA in these cells can trans-
mit to the next generations (13,14). Besides, long-term
exposure to chemotherapeutic agents leads to the induc-
tion of germ cell apoptosis, long-lasting azoospermia,
and infertility (9,10).
The testis is a very active organ which has prosurvival
and proapoptotic systems. These systems work together
to organize the germ cell apoptosis. Normally, the pro-
duction of germ cells is regulated by physiological apo-
ptosis in the seminiferous epithelium. However, on
exposure to testicular toxicants (e.g., chemotherapeutic
agents), apoptosis noticeably increases; the excessive
apoptotic-activity-induced dysfunction in seminiferous
epithelium results in severe injury in germ cells (15,16).
It has been reported in many studies that chemothera-
peutics lead to decreases in reproductive organ weights,
impairment of antioxidant defense mechanisms, and
increased free radicals (17–21) inducing testicular germ
cell apoptosis (22–24). Chemotherapeutics, despite their
strong antitumor activities, cause an increment in lipid
peroxidation levels and reduction in antioxidant enzyme
activities that prevent and/or protect testes against per-
oxidative damage (17–24). Normally, the generation of
reactive oxygen species (ROS; hydrogen peroxide, super-
oxide anion, and hydroxyl radical) is a physiologic event
in various organs, including the testes. However, the
overproduction of ROS causes DNA fragmentation and
impairs sperm function due to damaging effect of free
radicals on the mitochondria and plasma membrane.
Additionally, spermatozoa are especially vulnerable to
oxidative stress, associated with high concentration
of polyunsaturated fatty acids and low antioxidant
capacity (25).
Nowadays, many free radical scavengers and antioxi-
dant agents have been used in order to prevent damages
in testes and spermatozoa induced by chemotherapeu-
tics. For this purpose, some herbal antioxidants can be
used to block testicular oxidative stress. Cinnamon is an
herbal antioxidant and has also been used as a spice.
C. zeylanicum bark and leaf oils, C. cassia (cassia oil) and
C. camphora are the most important essential oils
extracted from cinnamon (26). Cinnamon bark oil
(CBO) has potent free radical scavenging and
antioxidant activities (27–29). Additionally, long-term
CBO consumption has been reported to provide incre-
ments in sperm quality and reproductive organ weights
in healthy (28) and carbon tetrachloride toxicated rats
(29) and reductions in toxicant-induced testicular apo-
ptosis by decreasing lipid peroxidation level (28). How-
ever, there is no scientific evidence related to the effects
of taxanes on sperm DNA integrity as well as impact of
CBO on taxanes-induced structural and functional dam-
ages in male reproductive system. Therefore, this study
was conducted to investigate whether CBO has protec-
tive effect on taxanes-induced adverse changes in sperm
quality, testicular apoptosis and histopathological
lesions, and sperm DNA fragmentation associated with
the oxidative stress.
Materials and methods
CBO, drugs, and chemicals
CBO was purchased from a local store (Altınterim Co.,
Elazıg, Turkey). According to the manufacturer’s proce-
dure, C. zeylanicum barks were transported in polypro-
pylene bags and dried to constant weight in room
temperature. CBO was obtained by hydrodistillation
method. The plant materials (about 100 g) were then
ground into small pieces and placed in a flask (2 l)
together with double distilled water (1.5 l). The mixture
was boiled for 4 h. The extract was condensed in cooling
vapor to collect the essential oil. The extracted oil was
dried over anhydrous sodium sulfate. The CBO used in
this study was previously analyzed using GC-MS by our
study group, and the components of CBO were reported
in a study by Şimşek et al. (30). In that study, the major
components of CBO were reported to be cinnamalde-
hyde (88.2%), benzyl alcohol (8.1%), and eugenol (1.0%).
The concentrations of other compounds were reported
to be 0.5% (30). CBO was kept at 4C until use. DTX
(Taxotere, 80 mg/2 ml) and PTX (Taxol, 100 mg/17
ml) were purchased from Sanofi-Aventis Inc. (_Istanbul,
Turkey) and Bristol-Myers Squibb Inc. (_Istanbul, Tur-
key), respectively. The other chemicals were obtained
from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).
Experimental protocol
The experimental protocol was approved by the Animal
Experimentations Local Ethics Committee of Erciyes
University (Kayseri, Turkey). Eighty-eight healthy adult
male Wistar albino rats, aged 2 months, were obtained
and maintained from Erciyes University Experimental
Research and Application Center (Kayseri, Turkey). The
animals were housed in polycarbonate cages in a room





























with a 12-h day/night cycle, temperature of 24 § 3C,
and humidity of 45–65%. During the whole experimental
period, animals were fed with a balanced commercial
diet (Optima Food Co., Bolu, Turkey) ad libitum and
fresh drinking water was given ad libitum.
CBO was administered by gavage at a dose of 100 mg/
kg/day for 10 weeks. To equalize the total amount (1 ml)
that each rat will receive in each application, CBO was
further suspended in corn oil and the CBO ratio in 1 ml
corn oil was adjusted according to the weight of each rat.
The dose of CBO used in this study was selected based
on the previous reports (28,29). DTX and PTX were
intraperitoneally injected during the experimental
period. Because the spermatogenesis is 7–8 weeks (31)
and epididymal transit of spermatozoa is 1–2 weeks (32)
in rats, the treatment period in this study was set out at
10 weeks to achieve the maximum effect. Each rat was
weighed weekly, and dosing suspensions were adjusted
for changes in body weights during experimental period.
The rats were randomly divided into eight groups, 11
animals each.
The groups established in this study were as follows:
- Control; received weekly 0.5 ml isotonic saline (i.p.)
C daily 1 ml corn oil (oral).
- CBO; treated with weekly 0.5 ml isotonic saline
(i.p.) C 100 mg/kg/day CBO within 1 ml corn oil
(oral).
- DTX; treated with weekly 5 mg/kg DTX in 0.5 ml
isotonic saline (i.p.) C daily 1 ml corn oil (oral).
- PTX; treated with weekly 4 mg/kg PTX in 0.5 ml
isotonic saline (i.p.) C daily 1 ml corn oil (oral).
- DTXCPTX; treated with weekly 5 mg/kg DTX (for
the first 5 weeks) C weekly 4 mg/kg PTX (for the
second 5 weeks) in 0.5 ml isotonic saline (i.p.) C
daily 1 ml corn oil (oral).
- DTXCCBO; treated with weekly 5 mg/kg DTX in
0.5 ml isotonic saline (i.p.) C 100 mg/kg/day CBO
in 1 ml corn oil (oral).
- PTXCCBO; treated with weekly 4 mg/kg PTX in
0.5 ml isotonic saline (i.p.) C 100 mg/kg/day CBO
in 1 ml corn oil (oral).
- DTXCPTXCCBO; treated with weekly 5 mg/kg
DTX (for the first 5 weeks) C weekly 4 mg/kg PTX
(for the second 5 weeks) in 0.5 ml isotonic saline
(i.p.) C 100 mg/kg/day CBO in 1 ml corn oil (oral).
Collection of samples
The rats were sacrificed using xylazine/ketamine anes-
thesia at the end of 10th week. The blood samples were
collected using a sterile injector from heart. Testes, epi-
didymides, seminal vesicles, and ventral prostate were
removed, cleared from adhering connective tissue, and
weighed. Absolute and relative (organ weight (g)/final
body weight (g) £ 100) reproductive organ weights were
recorded. The collected blood samples were centrifuged
at 3000 g for 10 min to obtain serum. One of the testis
samples was fixed in Bouin’s solution for histopatholog-
ical examination. The other testis samples and blood sera
were stored at ¡20C for biochemical analyses. Testes
were taken from a ¡20C freezer and immediately trans-
ferred to the cold glass tubes. Then, the testes were
diluted with a nine-fold volume of phosphate-buffered
saline (PBS) (pH 7.4). For the enzymatic analyses, testes
were minced in a glass and homogenized by a Teflon
glass homogenizer for 3 minutes in cold physiological
saline on ice.
Serum testosterone assay
The serum testosterone level was measured by electro-
chemiluminescence immunoassay (ECLIA) method and
commercial testosterone kit (Elecsys Testosterone II,
Roche Diagnostics Ltd., Rotkreuz, Switzerland) in the
device of Cobas e 602 module. The testosterone level was
expressed as ng/dL.
Determination of testicular and epididymal tissue
oxidative stress markers
All analyses were performed with the aid of a spectro-
photometer (Shimadzu 2R/UV-visible, Tokyo, Japan).
Lipid peroxidation level was measured according to the
concentration of thiobarbituric acid reactive substances,
and the amount of malondialdehyde (MDA) produced
was used as an index of lipid peroxidation. The MDA
level at 532 nm was expressed as nmol/g protein (33).
Reduced glutathione (GSH) level was measured using
the method described by Sedlak and Lindsay (34). The
level of GSH at 412 nm was expressed as nmol/g protein.
Glutathione peroxidase (GSH-Px, EC 1.11.1.9) activity
was determined according to the method described by
Lawrence and Burk (35). The GSH-Px activity at 340 nm
was expressed as IU/g protein. Catalase (CAT, EC
1.11.1.6) activity was determined by measuring the
decomposition of hydrogen peroxide (H2O2) at 240 nm
and was expressed as k/g protein, where k is the first-
order rate constant (36). Protein concentration was
determined by the method of Lowry et al. (37).
Sperm analyses
The methods reported in the studies of T€urk et al. (20,22)
were used for all the sperm analyses. The sperm count in
the right cauda epididymal tissue was determined with a
hemocytometer. Freshly isolated left cauda epididymal





























tissue was used for the analysis of sperm motility. The
percentage of sperm motility was evaluated using a light
microscope with a heated stage. To determine the per-
centage of morphologically abnormal spermatozoa,
slides stained with eosin-nigrosin (1.67% eosin, 10%
nigrosin, and 0.1 M of sodium citrate) were prepared.
The slides were then viewed under a phase-contrast
microscope at £400 magnification. A total of 300 sper-
matozoa were examined on each slide (3300 cells in each
group), and the head, tail, and total abnormality rates of
spermatozoa were expressed as percentage.
Histopathological examination
Testis tissues were fixed in Bouin’s solution for 48 h, they
were dehydrated through graded concentrations of etha-
nol, embedded in paraffin wax, sectioned at 5-mm thick-
nesses, and stained with Mayer’s hematoxylin and eosin.
Twenty seminiferous tubules were randomly examined
per section and the lesions were photographed. Diame-
ters of 20 seminiferous tubules (DST) per section were
measured using an ocular micrometer in a light micro-
scope. Johnsen’s testicular scoring (38) was done in 20
seminiferous tubules for each section, and a score
between 1 (very poor) and 10 (excellent) was given to
each tubule according to Johnsen’s criteria.
Determination of apoptotic germ cell number
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) assay with the ApopTag
Peroxidase in Situ Apoptosis Detection Kit (Chemicon,
Temecula, CA, USA) was used to detect apoptotic germ
cell number according to the manufacturer’s instruc-
tions. To detect TUNELC apoptotic germ cell number,
20 seminiferous tubules of each section were randomly
selected and examined at original magnification of £200.
TUNELC apoptotic germ cells were counted in the
defined areas with the aid of Image J software program
(version 1.41, Bethesda, MD, USA ) for quantitative his-
tomorphometric analysis and photographed.
Determination of sperm DNA fragmentation
by comet assay
Diluted sperm samples extracted from epididymis were
centrifuged at 300 g for 10 min at 4C. The supernatant
was removed and the remaining sperm cells were washed
with Ca2C and Mg2C free PBS (39). Sperms with frag-
mented DNA were determined using the single-cell gel
electrophoresis (comet) assay that was generally per-
formed at high alkaline conditions (40). The images of
100 randomly chosen nuclei from sperm sample of each
animal were visually analyzed and sperms with frag-
mented DNA were counted. Observations were made at a
magnification of £400 using a fluorescent microscope
(Olympus, Tokyo, Japan). Damage was detected by a tail
of fragmented DNA that migrated from the sperm head
causing a “comet” pattern, whereas whole sperm heads,
without a comet, were not considered to be damaged (41).
Statistical analysis
Data are presented as the mean § standard error of
mean (SEM). Nonparametric Kruskal-Wallis analysis of
variance test was used to determine the differences
between the groups, and nonparametric Mann-Whitney
U test with “Bonferroni correction” for multiple compar-
ison of the groups was used with respect to all parame-
ters studied. In this case, P value (0.05) was divided into
the number of groups and a P value of < 0.006 (0.05/8 D
0.006) was accepted as significant. All the analyses were
carried out using the SPSS/PC software program (Ver-
sion 22.0; SPSS, Chicago, IL, USA).
Results
Alterations in body and reproductive organ weights
DTX and mixed administration of DTXCPTX caused
significant (P < 0.001) decreases in the final body weight
compared to control group. These decreased values in
DTX and mixed groups were brought to values near that
of control group by CBO administration to chemothera-
peutics-treated rats.
The mean data related to the absolute and relative
reproductive organ weights are presented in Tables 1
and 2, respectively. The significant (P< 0.001) decreases
Figure 1. Alterations in final body weights in response to various
treatments. CBO: Cinnamon bark oil; DTX: Docetaxel; PTX: Pacli-
taxel. Data are expressed as mean§SEM. The difference between
the mean values that do not have the same superscript letter(s)
within the same column is statistically significant (P < 0.001).





























in the absolute weights of all reproductive organs were
found in only chemotherapeutics-treated groups com-
pared to control group. The lowest values of the absolute
reproductive organ weights were obtained from
DTXCPTX group. Besides, DTX had more damaging
effect than PTX. However, significant improvements
were determined in the absolute weights of whole epidid-
ymis, right cauda epididymis, seminal vesicles, and ven-
tral prostate in all treatments with the combination of
chemotherapeutics and CBO compared to only chemo-
therapeutic-treated groups (P < 0.001). DTX and
DTXCPTX groups had significant reductions in the rela-
tive weights of testis and whole epididymis (P < 0.001).
Only DTXCPTX administration caused a significant
decrease in the relative weight of seminal vesicles
(P < 0.001). All of the chemotherapeutic treatments
significantly reduced the relative weights of right cauda
epididymis and ventral prostate (P < 0.001) compared
to control group. However, CBO consumption by
chemotherapeutics-treated groups provided significant
improvements in relative weights of reproductive organs
(P < 0.001). The data related to relative weights of all
reproductive organs obtained from DTXCCBO,
PTXCCBO, and DTXCPTXCCBO groups were found
as near values to that in the control group due to the
positive effects of CBO on organ weights.
Alterations in serum testosterone level
Serum testosterone levels of all the groups are given in
Fig. 2. DTX, PTX, and their mixed administrations to
rats significantly reduced the testosterone level
(P < 0.001) compared to other experimental groups.
CBO administration to chemotherapeutics-treated rats
significantly enhanced the decreased testosterone level
compared to only chemotherapeutics-treated groups
(P < 0.001).
Alterations in testicular and epididymal tissue
oxidative stress markers
The data related to the lipid peroxidation levels (MDA)
and antioxidant markers (GSH, GSH-Px, and CAT) in
testes and epididymides of all the groups are given in
Table 1. Alterations in the absolute reproductive organ weights in response to various treatments.
Absolute reproductive organ weights (g)
Groups Testis (RightCleft/2) Whole epididymis (RightCleft/2) Right cauda epididymis Seminal vesicles Ventral prostate
Control 1.263 § 0.008ab 0.514 § 0.007a 0.186 § 0.003ab 1.126 § 0.052a 0.550 § 0.019ab
CBO 1.296 § 0.007a 0.547 § 0.013a 0.211 § 0.012a 1.247 § 0.061a 0.587 § 0.030a
DTX 0.706 § 0.054ef 0.307 § 0.012c 0.113 § 0.005c 0.657 § 0.027de 0.283 § 0.029e
PTX 0.980 § 0.035cd 0.423 § 0.007b 0.116 § 0.009c 0.821 § 0.026cd 0.339 § 0.010de
DTXCPTX 0.623 § 0.051f 0.297 § 0.015c 0.097 § 0.007c 0.619 § 0.053e 0.266 § 0.019e
DTXCCBO 0.933 § 0.029cd 0.379 § 0.025b 0.151 § 0.012b 0.929 § 0.035bc 0.393 § 0.018cd
PTXCCBO 1.095 § 0.047bc 0.486 § 0.016a 0.166 § 0.006b 1.069 § 0.041ab 0.509 § 0.029ab
DTXCPTXCCBO 0.829 § 0.037de 0.420 § 0.009b 0.170 § 0.003b 0.825 § 0.032cd 0.466 § 0.017bc
Significance P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
CBO: Cinnamon bark oil; DTX: Docetaxel; PTX: Paclitaxel.
Data are expressed as mean§SEM.
The difference between the mean values without the same superscript letter(s) within the same column is statistically significant (P < 0.001).
Table 2. Alterations in relative reproductive organ weights in response to various treatments.
Relative reproductive organ weights [Absolute organ weight (g) / Final body weight (g) £ 100]
Groups Testis (RightCleft/2) Whole epididymis (RightCleft/2) Right cauda epididymis Seminal vesicles Ventral prostate
Control 0.430 § 0.017a 0.175 § 0.007a 0.063 § 0.002a 0.381 § 0.014ab 0.187 § 0.009a
CBO 0.416 § 0.007a 0.176 § 0.005a 0.068 § 0.004a 0.401 § 0.022a 0.189 § 0.012a
DTX 0.308 § 0.020bc 0.136 § 0.007b 0.050 § 0.003bc 0.293 § 0.019bc 0.123 § 0.008b
PTX 0.348 § 0.021abc 0.152 § 0.011ab 0.042 § 0.004c 0.293 § 0.020bc 0.122 § 0.010b
DTXCPTX 0.282 § 0.019c 0.135 § 0.007b 0.044 § 0.003c 0.279 § 0.018ec 0.123 § 0.013b
DTXCCBO 0.382 § 0.031ab 0.155 § 0.007ab 0.060 § 0.003ab 0.377 § 0.031ab 0.158 § 0.014ab
PTXCCBO 0.385 § 0.016ab 0.171 § 0.008a 0.058 § 0.002ab 0.378 § 0.021ab 0.180 § 0.013a
DTXCPTXCCBO 0.311 § 0.018bc 0.158 § 0.005ab 0.064 § 0.003a 0.310 § 0.017bc 0.175 § 0.008a
Significance P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
CBO: Cinnamon bark oil; DTX: Docetaxel; PTX: Paclitaxel.
Data are expressed as mean § SEM.
The difference between the mean values without the same superscript letter(s) within the same column is statistically significant (P < 0.001).





























Table 3. All chemotherapeutic administrations resulted
in significantly (P< 0.001) increased MDA level and sig-
nificantly (P < 0.001) decreased GSH level and CAT
activity in testicular and epididymal tissues compared to
the control and CBO groups. The highest MDA level
was recorded in the DTXCPTX group in testicular and
epididymal tissues compared to the other chemothera-
peutic treatment groups. With respect to data related to
GSH-Px in testicular and epididymal tissues, no statisti-
cally significant difference was observed between all the
experimental groups. CBO administration to PTX- and
DTXCPTX-treated rats showed statistically significant
decreases in MDA level in comparison with the alone
PTX and DTXCPTX groups in testicular tissue (P <
0.001). However, in the epididymal tissue, CBO con-
sumption by DTX-, PTX-, and DTXCPTX-treated rats
significantly (P < 0.001) decreased the increments in
MDA levels in alone DTX, PTX, and DTXCPTX groups.
With respect to testicular tissue GSH levels, the statisti-
cally significant improvements were recorded in the
DTXCCBO, PTXCCBO, and DTXCPTXCCBO groups
in comparison with the groups given only chemothera-
peutics (P < 0.001). In epididymal tissue, only
PTXCCBO group provided a significant increase in GSH
level compared to PTX group (P < 0.001). Although a
significant (P < 0.001) increase was observed in testicu-
lar CAT activities of DTXCCBO and DTXCPTXCCBO
groups as compared to the DTX and DTXCPTX groups,
respectively, simultaneous administration of CBO to
DTX, PTX, and DTXCPTX groups had significant (P <
0.001) positive effect on epididymal CAT activity com-
pared to chemotherapeutics-treated groups not
consuming CBO.
Alterations in sperm parameters
Epididymal sperm motility, sperm concentration, and
abnormal sperm rate in all groups are presented in
Table 4. Significant decreases (P < 0.001) in sperm
motility and concentration as well as significant increases
(P < 0.001) in head, tail, and total abnormal sperm rates
were observed in chemotherapeutics-treated groups
compared to control group. Significant improvements
were observed in sperm motilities of DTXCCBO,
PTXCCBO, and DTXCPTXCCBO groups compared to
only chemotherapeutics-treated groups (P < 0.001).
Similarly, CBO consumption by PTX-treated rats signifi-
cantly enhanced the decreased epididymal sperm con-
centration in comparison to PTX group (P < 0.001).
Significant decreases (P < 0.001) in head and total
abnormality rates of spermatozoa were recorded in
DTXCCBO, PTXCCBO, and DTXCPTXCCBO groups
compared to only chemotherapeutics-treated groups.
Figure 2. Alterations in testosterone levels in response to various
treatments. CBO: Cinnamon bark oil; DTX: Docetaxel; PTX: Pacli-
taxel. Data are expressed as mean§SEM. The difference between
the mean values that do not have the same superscript letter(s)
within the same column is statistically significant (P < 0.001).



















Control 2.92 § 0.26d 13.64 § 0.37b 0.63 § 0.18 63.76 § 5.00ab 4.24 § 0.25de 17.69 § 0.99ab 1.29§ 0.37 48.51 § 6.22a
CBO 2.84 § 0.30d 17.64 § 1.10a 0.69 § 0.17 70.96 § 6.53a 2.73 § 0.20e 19.97 § 0.30a 1.49§ 0.14 57.80 § 6.42a
DTX 5.68 § 0.51bc 6.45§ 0.26d 0.17 § 0.04 24.91 § 3.96de 7.13 § 0.22b 8.27 § 0.61de 0.71§ 0.21 20.69 § 2.57c
PTX 5.26 § 0.15b 8.80§ 0.38c 0.35 § 0.10 40.26 § 1.81cd 6.10 § 0.23bc 9.97 § 0.43de 0.79§ 0.24 27.79 § 1.95bc
DTXCPTX 10.50 § 0.49a 6.21§ 0.33d 0.25 § 0.08 16.61 § 1.74e 11.49 § 0.76a 7.80 § 0.64e 0.57§ 0.11 18.59 § 1.83c
DTXCCBO 3.91 § 0.35cd 10.72 § 0.26c 0.53 § 0.13 45.06 § 5.27bc 5.04 § 0.49cd 13.14 § 0.94bcd 1.28§ 0.16 41.43 § 3.23ab
PTXCCBO 3.49 § 0.15d 11.43 § 0.35b 0.42 § 0.07 52.04 § 3.73abcd 4.30 § 0.28de 15.53 § 2.10abc 1.29§ 0.12 46.67 § 5.08a
DTXCPTXCCBO 5.29 § 0.28bc 9.96§ 1.06c 0.45 § 0.13 42.58 § 5.52cd 5.69 § 0.29bcd 11.37 § 0.66cde 1.08§ 0.18 40.56 § 4.01ab
Significance P < 0.001 P < 0.001 NS P < 0.001 P < 0.001 P < 0.001 NS P < 0.001
CBO: Cinnamon bark oil; DTX: Docetaxel; PTX: Paclitaxel; MDA: Malondialdehyde; GSH: Reduced Glutathione; GSH-Px: Glutathione peroxidase; CAT: Catalase; NS:
Non-significant.
Data are expressed as mean § SEM.
The difference between the mean values without the same superscript letter(s) within the same column is statistically significant (P < 0.001).





























CBO administration to DTX- and PTX-treated, but not
DTXCPTX-treated, rats significantly decreased the
abnormalities in sperm tail compared to only chemo-
therapeutics-treated groups (P < 0.001).
Alterations in testicular histological structure
Figure 3 demonstrates the changes observed in the testic-
ular tissue histological structure of each group. The sec-
tions of control (Fig. 3A) and CBO (Fig. 3B) groups
showed normal testicular architecture with normal germ
cell polarity and regular seminiferous tubular morphol-
ogy. The Sertoli cells between the germ cells were
observed to be normal in control and CBO groups. How-
ever, many histopathological changes such as degenera-
tion, desquamation, disorganization in germinal cells,
interstitial edema, capillary congestion, multinucleated
giant cell formation, and hemorrhage were observed in
the testis sections of DTX (Fig. 3C), PTX (Fig. 3D), and
DTXCPTX (Fig. 3E) groups compared to control group.
Many of the seminiferous tubules of DTX, PTX, and
DTXCPTX groups contained a great number of sper-
matogonia, but with a very few number of spermatocytes
and spermatids due to the spermatogenic arrest. Some
seminiferous tubules of chemotherapeutics-treated
groups were exactly empty. In addition, DTX, PTX, and
DTXCPTX administrations significantly (P < 0.001)
decreased the data related to DST and Johnsen’s testicu-
lar scoring when compared to control group (Table 5).
Although most of the lesions observed in only chemo-
therapeutics-treated rats were detected in DTXCCBO
(Fig. 3F), PTXCCBO (Fig. 3G), and DTXCPTXCCBO
(Fig. 3H) groups, there was a trend in decreased severity
of lesions by CBO administration to DTX-, PTX-, and
DTXCPTX-treated rats in comparison to only chemo-
therapeutics-treated groups.
Alterations in the apoptotic germ cells and sperm
DNA fragmentation
The microphotographic view of apoptotic germ cells and
their numbers in all groups are presented in Fig. 4 and
Table 5, respectively. There was no increase in
TUNELCapoptotic germ cell number in the testis tissues
of control (Fig. 4A) and CBO (Fig. 4B) groups.
TUNELCapoptotic germ cell numbers in 20 seminifer-
ous tubules in groups of DTX (Fig. 4C), PTX (Fig. 4D),
and DTXCPTX (Fig. 4E) were statistically (P < 0.001)
higher than that of the control group (Table 5). Statisti-
cally significant decreases (P < 0.001) were observed in
TUNELCapoptotic germ cell numbers of DTXCCBO
(Fig. 4F), PTXCCBO (Fig. 4G), and DTXCPTXCCBO
(Fig. 4H) groups compared to only chemotherapeutics-
treated groups.
Microphotographic view of sperms with fragmented
DNA and their numbers in all groups are presented in
Fig. 5 and Table 5, respectively. Only CBO (Fig. 5B)
administration significantly (P < 0.001) decreased the
rate of sperm DNA fragmentation in comparison to the
control (Fig. 5A) group. The rate of sperm DNA frag-
mentation was statistically (P < 0.001) higher in DTX
(Fig. 5C), PTX (Fig. 5D), and DTXCPTX (Fig. 5E)
groups than that of control group. Statistically significant
decreases (P < 0.001) were observed in the rate of sperm
DNA fragmentation in DTXCCBO (Fig. 5F), PTXCCBO
(Fig. 5G), and DTXCPTXCCBO (Fig. 5H) groups com-
pared to only chemotherapeutics-treated groups.
Discussion
Damaging effect of taxanes
The taxane class compounds (DTX and PTX) are the
most important cancer chemotherapeutics. Both com-
pounds have a similar mechanism of action and broad-
Table 4. Alterations in sperm parameters in response to various treatments.
Sperm parameters
Abnormal sperm rate (%)
Groups Motility (%) Concentration (million/right cauda epididymis) Head Tail Total
Control 77.62 § 1.40a 118.28 § 5.95a 3.86§ 0.74f 3.29§ 0.42e 7.15 § 0.77f
CBO 88.09 § 0.68a 135.14 § 3.86a 3.43§ 0.57f 2.86§ 0.40e 6.29 § 0.78f
DTX 17.14 § 3.89de 50.86 § 1.25cd 28.14 § 4.20c 15.14 § 1.55b 43.28 § 5.03c
PTX 22.92 § 3.96cde 47.76 § 1.97d 22.25 § 1.25cd 11.13 § 0.64c 33.38 § 1.65cd
DTXCPTX 11.66 § 0.82e 42.58 § 0.71cd 56.00 § 1.38a 19.86 § 0.55a 75.86 § 1.87a
DTXCCBO 33.33 § 5.25c 74.86 § 1.99bc 15.86 § 0.63de 8.71§ 0.42cd 24.57 § 0.75de
PTXCCBO 55.41 § 2.11b 91.50 § 2.17b 13.00 § 1.25e 7.75§ 0.42d 20.75 § 1.18e
DTXCPTXCCBO 26.19 § 3.04cd 66.58 § 1.09bcd 43.71 § 2.93b 17.43 § 0.95ab 61.14 § 2.72b
Significance P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.001
CBO: Cinnamon bark oil; DTX: Docetaxel; PTX: Paclitaxel.
Data are expressed as mean § SEM.
The difference between the mean values without the same superscript letter(s) within the same column is statistically significant (P < 0.001).





























spectrum antitumor activity in the treatment of a wide
variety of cancers (prostate, breast, ovary, and lung can-
cer). However, there are very limited numbers of scien-
tific studies about the effects of both chemotherapeutics
on male reproductive system. According to our knowl-
edge, there is no evidence concerning the impact of these
drugs on sperm DNA integrity. In the present study, the
organs, tissues, and cells of male reproductive system
were examined in detail to observe the possible adverse
effects of both drugs and the improvement effect of a
protective agent, CBO.
Chemotherapeutics, despite their strong antitumor
activities, also have toxic effects on the reproductive sys-
tem as in many systems. It has been reported in many
studies that chemotherapeutics (18–20,24) including
DTX (42,43) and PTX (42,44) lead to a decrease in
Figure 3. Microphtographic views of testicular histological structure in control (A), cinnamon bark oil (B), docetaxel (C), paclitaxel (D),
docetaxelCpaclitaxel (E), docetaxelCcinnamon bark oil (F), paclitaxelCcinnamon bark oil (G), and docetaxelCpaclitaxelCcinnamon
bark oil (H) groups (Hematoxylin and Eosin staining).





























reproductive organ weights. In the present study, the
final body weight (DTX and DTXCPTX) and absolute
weights of all reproductive organs as well as relative
weights of right cauda epididymis and ventral prostate of
chemotherapeutics-treated rats were significantly
reduced. Besides, in the present study, DTX, PTX, and
their mixed administrations to healthy rats caused a sig-
nificant reduction in the level of testosterone. According
to the findings of our study, the measurement of reduced
testosterone level confirms the detrimental effect of tax-
anes on testis functions. This finding is in agreement
with the results of a previous study performed by Altin-
tas et al. (43) in which a weak expression of testosterone
was observed in the Leydig cells of DTX-treated rats.
Additionally, many studies have also reported that che-
motherapeutics exhibit a harmful effect on testosterone
level (22,24). Decrease in testicular testosterone expres-
sion due to the Leydig cell impairment and increased
lipid peroxidation may possibly be responsible for the
reductions observed in body and reproductive organ
weights in the present study because permanent testos-
terone secretion is needed for body metabolism, and
growth and functions of the reproductive organs.
When the taxanes are used for the therapy, oxidative
stress develops depending on overproduction of ROS,
which also leads to decrease in the antioxidant enzyme
level. This situation demonstrates that taxanes toxicity
plays a detrimental role in liver tissue (45). The chemo-
therapeutics like cisplatin (17,18,20,23), adriamycin
(19,24), and cyclophosphamide (22), which are fre-
quently used in cancer treatment, have been reported to
deteriorate testicular oxidant-antioxidant balance. How-
ever, only one study (43) has been conducted related to
the damaging effect of DTX on redox balance (increased
MDA level and decreased superoxide dismutase, GSH,
and GSH-Px activities) of testicular tissue so far. There is
no study about the effects of PTX or DTXCPTX admin-
istrations on testicular and epididymal lipid peroxidation
and antioxidant enzyme activity. In the present study,
DTX, PTX, and their mixed administrations resulted in
significantly increased MDA level—an indicator of lipid
peroxidation—and significantly decreased GSH level and
CAT activity in testicular and epididymal tissues com-
pared to control group. The highest MDA level in testic-
ular and epididymal tissues was recorded in the mixed
group compared to the other chemotherapeutic treat-
ment groups. The probable reason for this imbalance in
redox status of testicular and epididymal tissue is the
increased free radicals after the administrations of
taxanes.
Normally, small amounts of ROS are produced in
spermatozoa, which play a beneficial role in sperma-
tological process. However, spermatozoa are highly
vulnerable to oxidative stress induced by excessive
production of ROS because their cytoplasm has lim-
ited scavenging antioxidant enzyme and large amount
of polyunsaturated fatty acids (46). It has been dem-
onstrated in many studies (17–20,22,24) that different
chemotherapeutics cause reductions in sperm count
and motility, and increment in abnormal and death
sperm rate. Besides, DTX (43) and PTX (44) adminis-
trations to rats have been reported to decrease sperm
motility and count, and increase abnormal sperm
rate. In this study, DTX, PTX, and their mixed
administrations resulted in significantly decreased
sperm motility and concentration as well as signifi-
cantly increased total abnormal sperm rates compared
to control group. The deteriorations in sperm param-
eters in the present study may be explained by testic-
ular and epididymal oxidative stress, as evidenced by
increased MDA and decreased GSH and CAT, and
decreased testosterone level or their combined effects.
The testes are the target organs of chemotherapeutic
agents and their use adversely affects the structure of tes-
tis and functionality of spermatogenesis by reducing the
DST and the number of germ cells and by increasing
Table 5. Alterations in diameter of seminiferous tubules, Johnsen’s testicular scoring, TUNELCapoptotic germ cell number, and sperm
DNA fragmentation in response to various treatments.
Parameters
Groups DST(mm) Johnsen’s testicular scoring TUNELCapoptotic germ cell number Sperm DNA fragmentation (%)
Control 270.99 § 4.42ab 9.58§ 0.15a 0.26 § 0.06a 3.23§ 0.07a
CBO 279.47 § 2.73a 9.35§ 0.82a 0.45 § 0.09a 1.10§ 0.02b
DTX 218.56 § 3.95ef 5.64§ 0.13cd 4.97 § 0.71b 11.11 § 0.12c
PTX 229.53 § 3.75de 5.88§ 0.17c 4.75 § 0.73b 10.81 § 0.11c
DTXCPTX 205.21 § 6.19f 5.17§ 0.16d 5.28 § 0.61b 11.51 § 0.11d
DTXCCBO 230.71 § 3.87de 6.80§ 0.18b 1.29 § 0.17a 8.53§ 0.08e
PTXCCBO 255.68 § 2.98bc 7.44§ 0.14b 0.69 § 0.14a 8.13§ 0.08f
DTXCPTXCCBO 239.61 § 3.02cd 6.90§ 0.18b 1.64 § 0.28a 9.32§ 0.10g
Significance P < 0.001 P < 0.001 P < 0.001 P < 0.001
DST: Diameter of seminiferous tubules; CBO: Cinnamon bark oil; DTX: Docetaxel; PTX: Paclitaxel.
Data are expressed as mean § SEM.
The difference between the mean values without the same superscript letter(s) within the same column is statistically significant (P < 0.001).





























germ cell maturation arrest (17,19–21,24) and apoptosis
(22,23) through oxidative stress. It has been demon-
strated that DTX (43) and PTX (44) administrations to
rats cause significant structural damages in testis, and
DTX reduces the testicular testosterone receptors due to
the Leydig cell impairment and oxidative stress. The
most significant marker of DNA damage in the cells
including spermatogenic cells is apoptosis, which
resulted from overproduction of free radicals (47). The
rat sperm nuclear chromatin is condensed by disulfide
bonds within the testis and especially during epididymal
transit. Therefore, high condensation of chromatin
makes nuclei of spermatozoa resistant to DNA damage
induced by various agents (48). However, lipid peroxides
formed during lipid peroxidation and other ROS cause
damage to sperm DNA through oxidation of purine and
pyrimidine bases of DNA (49). Exposure to many toxi-
cants containing chemotherapeutics has been reported
to result in increased testicular apoptosis (22,24).
Besides, sperm DNA integrity is necessary for the
Figure 4. A: Microphotographic views of TUNELC apoptotic germ cells in testicular tissue of control, B: CBO, C: DTX, D: PTX, E: DTXCPTX,
F: DTXCCBO, G: PTXCCBO, and H: DTXCPTXCCBO groups (TUNEL staining).





























transmission of genetic information to the future genera-
tions. Therefore, sperm DNA integrity is a more objec-
tive indicator of sperm function versus sperm
parameters such as motility (50). However, there is no
evidence related to the effects of DTX and PTX on testic-
ular apoptosis and sperm DNA integrity. In the present
study, aforementioned similar structural damages in tes-
tis histology, and increased testicular apoptosis and
sperm DNA fragmentation were observed in the testis
sections of DTX, PTX, and DTXCPTX groups compared
to control group. The possible reason of damages in the
histological structure of testis and as well as elevation in
apoptotic cell rates and sperm DNA fragmentation that
were observed in the present study may be explained
with the direct or indirect effects of DTX-, PTX- and
their mixed application-induced lipid peroxidation,
which is a chemical mechanism capable of disrupting the
structure and function of testis.
Figure 5. A: Microphotographic views of sperm DNA fragmentation in control, B: CBO, C: DTX, D: PTX, E: DTXCPTX, F: DTXCCBO, G:
PTXCCBO, and H: DTXCPTXCCBO groups (Ethidium bromide staining).





























Beneficial effect of CBO
The leaves and barks of C. zeylanicum are used as spices
and for the production of volatile oils. CBO is one of the
most important volatile oils. Although there is no evi-
dence about the effect of cinnamaldehyde, which is the
major component of CBO used in this study, on sperm
parameters, testis structure, and sperm DNA integrity, it
has been reported that ingestion of plant extract contain-
ing cinnamaldehyde effectively protects pig lymphocytes
against oxidative DNA damage (51). Oil and other prod-
ucts of C. zeylanicum have been reported to result in
decrease in testicular lipid peroxidation levels, and
increases in LH, FSH, and testosterone (52,53) concen-
trations; reproductive organ weights; sperm count and
motility; antioxidant activities (GSH, GSH-Px, and
CAT); and DST in healthy animals (28). Besides, long-
term CBO administration has been demonstrated to pro-
tect testes, epididymides, accessory sex organs, and sper-
matozoa, and to decrease testicular apoptosis against
carbon-tetrachloride-induced reproductive toxicity by
preventing oxidative stress (29). In this study, CBO
administration to DTX-treated rats led to significant
increases in the absolute weights of all reproductive
organs, testosterone level, sperm motility, testicular GSH
level, and epididymal CAT activity, and significant
decreases in head, tail, and total abnormal sperm rates,
epididymal MDA level, severity of testicular histopatho-
logical lesions, apoptosis, and sperm DNA fragmentation
compared to only DTX-treated rats. When PTXCCBO
group was compared to only DTX group, significant
increases in the absolute weights of reproductive organs
except testis, relative weights of right cauda epididymis
and ventral prostate, testosterone level, sperm motility
and concentration, testicular and epididymal GSH level,
epididymal CAT activity, and significant decreases in
head, tail, and total abnormal sperm rates, testicular and
epididymal MDA level, severity of testicular histopatho-
logical lesions, apoptosis, and sperm DNA fragmentation
were found in DTXCCBO group. Besides, significant
increments in the absolute weights of all reproductive
organs, relative weights of right cauda epididymis and
ventral prostate, testosterone level, sperm motility, testic-
ular GSH level, testicular and epididymal CAT activity,
and significant decreases in head and total abnormal
sperm rates, testicular and epididymal MDA level, sever-
ity of testicular histopathological lesions, apoptosis, and
sperm DNA fragmentation were determined in
DTXCPTXCCBO group in comparison to the only
DTXCPTX group. The possible explanation for these
ameliorations after CBO administration to DTX-, PTX-,
or DTXCPTX-treated rats may be the prevention of
imbalance in oxidant-antioxidant system by CBO.
In conclusion, the results of this study clearly suggest
that DTX and PTX cause impairment in reproductive
organs, tissues, and cells by decreasing reproductive
organ weights, serum testosterone level, and sperm
motility and concentration, and by increasing abnormal
sperm rates, testicular apoptosis, and sperm DNA frag-
mentation rates as well as inducing testicular tissue histo-
pathological lesions. These impairments in male
reproductive system are potently related to taxanes-
induced increment in lipid peroxidation level and reduc-
tion in antioxidant enzyme activities. In addition, the
findings of the present study obviously indicate that
long-term CBO consumption protects male reproductive
organs, tissues, and cells of rats against structural and
functional damages of taxanes by its antiperoxidative
effect. However, additional physiologic and metabolic
changes could not be observed, because inhibitory effects
of taxanes on cancer growth were not examined in this
study. In addition, it might not be revealed how the pro-
tective activity of CBO on gonads will be impressed
because certain types of cancer can synthesize androgens
and other steroids that have an impact on the sexual
organs. Therefore, there is a need for further studies con-
taining cancer induction.
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dant activity of cinnamon bark oil (Cinnamomum zeylani-
cum L.) in Japanese quails under thermo neutral and heat
stressed conditions. Kafkas Univ Vet Fak Derg 19, 889–
894, 2013.
31. Bennett JP, and Vickery BH: Rats and mice. In: Reproduc-
tion and Breeding Techniques for Laboratory Animals,
Hafez ESE (ed). Philadelphia, USA: Lea and Febiger, 1970,
pp. 299–315.
32. Kempinas WDG, Suarez JD, Roberts NL, Strader L, Ferrell
J, et al.: Rat epididymal sperm quantity, quality, and transit
time after guanethidine-induced sympathectomy. Biol
Reprod 59, 890–896, 1998.
33. Placer ZA, Cushman LL, and Johnson BC: Estimation
of product of lipid peroxidation (malonyl dialdehyde)
in biochemical systems. Anal Biochem 16, 359–364,
1966.
34. Sedlak J, and Lindsay RH: Estimation of total, protein-
bound and nonprotein sulfhydryl groups in tissue with
Ellman’s reagent. Anal Biochem 25, 192–205, 1968.
35. Lawrence RA, and Burk RF: Glutathione peroxidase activ-
ity in selenium-deficient rat liver. Biochem Biophys Res
Commun 71, 952–958, 1976.





























36. Aebi H: Catalase. In: Methods in Enzymatic Analysis, Berg-
meyer HU (ed). New York, USA: Academic Press, 1983, pp.
276–286.
37. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ: Pro-
tein measurement with folin phenol reagent. J Biol Chem
193, 265–275, 1951.
38. Johnsen SG: Testicular biopsy score count a method for
registration of spermatogenesis in human normal values
and results in 335 hypogonadal males. Hormones 1, 2–25,
1970.
39. Arabi M: Bull spermatozoa under mercury stress. Reprod
Domest Anim 40, 454–459, 2005.
40. Haines G, Marples B, Daniel P, and Morris I: DNA dam-
age in human and mouse spermatozoa after in vitro-irra-
diation assessed by the comet assay. Adv Exp Med Biol
444, 789–791, 1998.
41. Verit FF, Verit A, Kocyigit A, Ciftci H, Celik H, et al.: No
increase in sperm DNA damage and seminal oxidative
stress in patients with idiopathic infertility. Arch Gynecol
Obstet 274, 339–344, 2006.
42. Chatzidarellis E, Makrilia N, Giza L, Georgiadis E, Ala-
mara C, et al.: Effects of taxane-based chemotherapy on
inhibin B and gonadotropins as biomarkers of spermato-
genesis. Fertil Steril 94, 558–563, 2010.
43. Altintas R, Ciftci O, Aydin M, Akpolat N, Oguz F,
et al.: Quercetin prevents docetaxel-induced testicular
damage in rats. Andrologia, in press. doi: 10.1111/
and.12253, 2014
44. Koehler-Samouillidou G, Kaldrymidou E, Papaioannou N,
Kotsaki-Kovatsi VP, and Vadarakis A: The effect of pacli-
taxel (taxol) on the reproductive system and the semen
parameters as well as on other organs of male rats. J Hell
Vet Med Soc 52, 23–31, 2001.
45. Pieniazek A, Czepas J, Piasecka-Zelga J, Gwozdzinski K,
and Koceva-Chyla A: Oxidative stress induced in rat liver
by anticancer drugs doxorubicin, paclitaxel and docetaxel.
Adv Med Sci 58, 104–111, 2013.
46. Agarwal A, and Saleh RA: Role of oxidants in male infer-
tility: rationale, significance, and treatment. Urol Clin
North Am 29, 817–827, 2002.
47. Maheshwari A, Misro MM, Agarwal A, Sharma RK, and
Nandan D: Pathways involved in testicular germ cell apo-
ptosis induced by H2O2 in vitro. FEBS J 276, 870–881, 2009.
48. Chapman JC, and Michael SD: Proposed mechanism for
sperm chromatin condensation/decondensation in the
male rat. Reprod Biol Endocrinol 1, 1–7, 2003.
49. Saraswat S, Kharche SD, and Jindal SK: Impact of reactive
oxygen species on spermatozoa: a balancing act between
beneficial and detrimental effects. Iranian J Appl Anim Sci
4, 247–255, 2014.
50. Love CC, Brinsko SP, Rigby SL, Thompson JA, Blanchard
TL, et al.: Relationship of seminal plasma level and
extender type to sperm motility and DNA integrity. Ther-
iogenology 63, 1584–1591, 2005.
51. Frankic T, Levart A, and Salobir J: The effect of vita-
min E and plant extract mixture composed of carva-
crol, cinnamaldehyde and capsaicin on oxidative stress
induced by high PUFA load in young pigs. Animal 4,
572–578, 2010.
52. Modaresi M, Messripour M, and Rajaei R: The effect of
cinnamon (bark) extract on male reproductive physiology
in mice. Armaghan Danesh 14, 67–77, 2009.
53. Hemayatkhah Jahromi V, Parivar K, and Forozanfar M:
The effect of cinnamon extract on spermatogenesis hor-
monal axis of pituitary gonad in mice. Iran J Appl Anim
Sci 1, 99–103, 2011.
494 S. SARI€OZKAN ET AL.
D
ow
nl
oa
de
d 
by
 [
Fi
ra
t U
ni
ve
rs
ite
si
] 
at
 0
7:
55
 0
1 
M
ay
 2
01
6 
